[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

VPAResearch: Market Research Reports

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.

Publications found: 58,333
Sort by:

African Trypanosomiasis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for African Trypanosomiasis

US$ 1,080.00

African Trypanosomiasis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of African Trypanosomiasis Infection pipeline products. DISEASE OVERVIEW African Trypanosomiasis infection is spread through Clostridium tetani bacteria ...

September 2018 65 pages

Bacillary Dysentery (Shigellosis) Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Bacillary Dysentery (Shigellosis)

US$ 1,080.00

Bacillary Dysentery (Shigellosis) Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Bacillary Dysentery (Shigellosis) Infection pipeline products. DISEASE OVERVIEW Bacillary Dysentery (Shigellosis) infection is spread through ...

September 2018 65 pages

Bacterial Vaginosis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Bacterial Vaginosis

US$ 1,080.00

Bacterial Vaginosis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Bacterial Vaginosis Infection pipeline products. DISEASE OVERVIEW Bacterial Vaginosis infection is spread through Clostridium tetani bacteria ...

September 2018 65 pages

Candidiasis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Candidiasis

US$ 1,080.00

Candidiasis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Candidiasis Infection pipeline products. DISEASE OVERVIEW Candidiasis infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Cholera Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Cholera

US$ 1,080.00

Cholera Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Cholera Infection pipeline products. DISEASE OVERVIEW Cholera infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Coccidioidomycosis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Coccidioidomycosis

US$ 1,080.00

Coccidioidomycosis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Coccidioidomycosis Infection pipeline products. DISEASE OVERVIEW Coccidioidomycosis infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Cryptococcosis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Cryptococcosis

US$ 1,080.00

Cryptococcosis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Cryptococcosis Infection pipeline products. DISEASE OVERVIEW Cryptococcosis infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Eastern Equine Encephalitis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Eastern Equine Encephalitis

US$ 1,080.00

Eastern Equine Encephalitis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Eastern Equine Encephalitis Infection pipeline products. DISEASE OVERVIEW Eastern Equine Encephalitis infection is spread through Clostridium ...

September 2018 65 pages

Epstein–Barr Virus (HHV-4) Infections Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Epstein–Barr Virus (HHV-4) Infections

US$ 1,080.00

... format. SCOPE OF EPSTEIN–BARR VIRUS (HHV-4) INFECTIONS INFECTION PIPELINE REPORT INCLUDES Panorama of Epstein–Barr Virus (HHV-4) Infections Infection pipeline markets including statistics on therapeutic drugs and companies involved Epstein–Barr Virus (HHV-4) Infections Infection Pipeline candidates across ...

September 2018 65 pages

Equine Encephalitis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Equine Encephalitis

US$ 1,080.00

Equine Encephalitis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Equine Encephalitis Infection pipeline products. DISEASE OVERVIEW Equine Encephalitis infection is spread through Clostridium tetani bacteria ...

September 2018 65 pages

Genital Herpes Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Genital Herpes

US$ 1,080.00

Genital Herpes Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Genital Herpes Infection pipeline products. DISEASE OVERVIEW Genital Herpes infection is spread through Clostridium tetani bacteria ...

September 2018 65 pages

Gonorrhea Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Gonorrhea

US$ 1,080.00

Gonorrhea Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Gonorrhea Infection pipeline products. DISEASE OVERVIEW Gonorrhea infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Influenza A Virus H3N2 Subtype Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Influenza A Virus H3N2 Subtype

US$ 1,080.00

... . SCOPE OF INFLUENZA A VIRUS H3N2 SUBTYPE INFECTION PIPELINE REPORT INCLUDES Panorama of Influenza A Virus H3N2 Subtype Infection pipeline markets including statistics on therapeutic drugs and companies involved Influenza A Virus H3N2 Subtype Infection Pipeline ...

September 2018 65 pages

Influenza A virus H5N1 subtype Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Influenza A virus H5N1 subtype

US$ 1,080.00

... . SCOPE OF INFLUENZA A VIRUS H5N1 SUBTYPE INFECTION PIPELINE REPORT INCLUDES Panorama of Influenza A virus H5N1 subtype Infection pipeline markets including statistics on therapeutic drugs and companies involved Influenza A virus H5N1 subtype Infection Pipeline ...

September 2018 65 pages

Influenza A Virus H7N9 Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Influenza A Virus H7N9

US$ 1,080.00

... format. SCOPE OF INFLUENZA A VIRUS H7N9 INFECTION PIPELINE REPORT INCLUDES Panorama of Influenza A Virus H7N9 Infection pipeline markets including statistics on therapeutic drugs and companies involved Influenza A Virus H7N9 Infection Pipeline candidates across ...

September 2018 65 pages

Lassa Hemorrhagic Fever Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Lassa Hemorrhagic Fever

US$ 1,080.00

Lassa Hemorrhagic Fever Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Lassa Hemorrhagic Fever Infection pipeline products. DISEASE OVERVIEW Lassa Hemorrhagic Fever infection is spread through Clostridium ...

September 2018 65 pages

Marburgvirus Infections Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Marburgvirus Infections

US$ 1,080.00

... ready to use format. SCOPE OF MARBURGVIRUS INFECTIONS INFECTION PIPELINE REPORT INCLUDES Panorama of Marburgvirus Infections Infection pipeline markets including statistics on therapeutic drugs and companies involved Marburgvirus Infections Infection Pipeline candidates across various development ...

September 2018 65 pages

Meningitis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Meningitis

US$ 1,080.00

Meningitis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Meningitis Infection pipeline products. DISEASE OVERVIEW Meningitis infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Osteomyelitis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Osteomyelitis

US$ 1,080.00

Osteomyelitis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Osteomyelitis Infection pipeline products. DISEASE OVERVIEW Osteomyelitis infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Plague Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Plague

US$ 1,080.00

Plague Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Plague Infection pipeline products. DISEASE OVERVIEW Plague infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Poliomyelitis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Poliomyelitis

US$ 1,080.00

Poliomyelitis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Poliomyelitis Infection pipeline products. DISEASE OVERVIEW Poliomyelitis infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Pyelonephritis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Pyelonephritis

US$ 1,080.00

Pyelonephritis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Pyelonephritis Infection pipeline products. DISEASE OVERVIEW Pyelonephritis infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Rhinovirus Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Rhinovirus

US$ 1,080.00

Rhinovirus Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Rhinovirus Infection pipeline products. DISEASE OVERVIEW Rhinovirus infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Schistosomiasis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Schistosomiasis

US$ 1,080.00

Schistosomiasis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Schistosomiasis Infection pipeline products. DISEASE OVERVIEW Schistosomiasis infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Severe Acute Respiratory Syndrome (SARS) Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Severe Acute Respiratory Syndrome (SARS)

US$ 1,080.00

... . SCOPE OF SEVERE ACUTE RESPIRATORY SYNDROME (SARS) INFECTION PIPELINE REPORT INCLUDES Panorama of Severe Acute Respiratory Syndrome (SARS) Infection pipeline markets including statistics on therapeutic drugs and companies involved Severe Acute Respiratory Syndrome (SARS) Infection Pipeline ...

September 2018 65 pages

Shingles Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Shingles

US$ 1,080.00

Shingles Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Shingles Infection pipeline products. DISEASE OVERVIEW Shingles infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Tinea pedis (Athlete Foot) Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Tinea pedis (Athlete Foot)

US$ 1,080.00

... format. SCOPE OF TINEA PEDIS (ATHLETE FOOT) INFECTION PIPELINE REPORT INCLUDES Panorama of Tinea pedis (Athlete Foot) Infection pipeline markets including statistics on therapeutic drugs and companies involved Tinea pedis (Athlete Foot) Infection Pipeline candidates across ...

September 2018 65 pages

Toxoplasmosis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Toxoplasmosis

US$ 1,080.00

Toxoplasmosis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Toxoplasmosis Infection pipeline products. DISEASE OVERVIEW Toxoplasmosis infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Warts Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Warts

US$ 1,080.00

Warts Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Warts Infection pipeline products. DISEASE OVERVIEW Warts infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

West Nile Virus Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for West Nile Virus

US$ 1,080.00

West Nile Virus Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of West Nile Virus Infection pipeline products. DISEASE OVERVIEW West Nile Virus infection is spread through Clostridium ...

September 2018 65 pages

Western Equine Encephalitis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Western Equine Encephalitis

US$ 1,080.00

Western Equine Encephalitis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Western Equine Encephalitis Infection pipeline products. DISEASE OVERVIEW Western Equine Encephalitis infection is spread through Clostridium ...

September 2018 65 pages

Achondroplasia R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... is presented in user friendly and ready to use format. SCOPE OF ACHONDROPLASIA PIPELINE REPORT INCLUDES Panorama of Achondroplasia pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 30 pages

Acid Sphingomyelinase Deficiency (NPD C) R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... format. SCOPE OF ACID SPHINGOMYELINASE DEFICIENCY (NPD C) PIPELINE REPORT INCLUDES Panorama of Acid Sphingomyelinase Deficiency (NPD C) pipeline markets including statistics on therapeutic drugs and companies involved Acid Sphingomyelinase Deficiency (NPD C) Pipeline candidates across ...

August 2018 60 pages

Acinetobacter Infections R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF ACINETOBACTER INFECTIONS PIPELINE REPORT INCLUDES Panorama of Acinetobacter Infections pipeline markets including statistics on therapeutic drugs and companies involved Acinetobacter Infections Pipeline candidates across various development ...

August 2018 120 pages

Acne Vulgaris R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF ACNE VULGARIS PIPELINE REPORT INCLUDES Panorama of Acne Vulgaris pipeline markets including statistics on therapeutic drugs and companies involved Acne Vulgaris Pipeline candidates across various development ...

August 2018 150 pages

Acromegaly R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... is presented in user friendly and ready to use format. SCOPE OF ACROMEGALY PIPELINE REPORT INCLUDES Panorama of Acromegaly pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 60 pages

Actinic (Solar) Keratosis R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF ACTINIC (SOLAR) KERATOSIS PIPELINE REPORT INCLUDES Panorama of Actinic (Solar) Keratosis pipeline markets including statistics on therapeutic drugs and companies involved Actinic (Solar) Keratosis Pipeline candidates across various development ...

August 2018 50 pages

Acute Coronary Syndrome R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF ACUTE CORONARY SYNDROME PIPELINE REPORT INCLUDES Panorama of Acute Coronary Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Acute Coronary Syndrome Pipeline candidates across various development ...

August 2018 90 pages

Acute Heart Failure R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF ACUTE HEART FAILURE PIPELINE REPORT INCLUDES Panorama of Acute Heart Failure pipeline markets including statistics on therapeutic drugs and companies involved Acute Heart Failure Pipeline candidates across various development ...

August 2018 60 pages

Acute Ischemic Stroke R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF ACUTE ISCHEMIC STROKE PIPELINE REPORT INCLUDES Panorama of Acute Ischemic Stroke pipeline markets including statistics on therapeutic drugs and companies involved Acute Ischemic Stroke Pipeline candidates across various development ...

August 2018 100 pages

Acute Lung Injury R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF ACUTE LUNG INJURY PIPELINE REPORT INCLUDES Panorama of Acute Lung Injury pipeline markets including statistics on therapeutic drugs and companies involved Acute Lung Injury Pipeline candidates across various development ...

August 2018 80 pages

Acute Pain R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF ACUTE PAIN PIPELINE REPORT INCLUDES Panorama of Acute Pain pipeline markets including statistics on therapeutic drugs and companies involved Acute Pain Pipeline candidates across various development ...

August 2018 160 pages

Acute Renal Failure (ARF) R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... format. SCOPE OF ACUTE RENAL FAILURE (ARF) PIPELINE REPORT INCLUDES Panorama of Acute Renal Failure (ARF) pipeline markets including statistics on therapeutic drugs and companies involved Acute Renal Failure (ARF) Pipeline candidates across ...

August 2018 100 pages

Acute Respiratory Distress Syndrome R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... format. SCOPE OF ACUTE RESPIRATORY DISTRESS SYNDROME PIPELINE REPORT INCLUDES Panorama of Acute Respiratory Distress Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Acute Respiratory Distress Syndrome Pipeline candidates across ...

August 2018 80 pages

Acute Sensorineural Hearing Loss R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... format. SCOPE OF ACUTE SENSORINEURAL HEARING LOSS PIPELINE REPORT INCLUDES Panorama of Acute Sensorineural Hearing Loss pipeline markets including statistics on therapeutic drugs and companies involved Acute Sensorineural Hearing Loss Pipeline candidates across ...

August 2018 40 pages

Adrenocortical Carcinoma (Adrenal Cortex Cancer) R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... format. SCOPE OF ADRENOCORTICAL CARCINOMA (ADRENAL CORTEX CANCER) PIPELINE REPORT INCLUDES Panorama of Adrenocortical Carcinoma (Adrenal Cortex Cancer) pipeline markets including statistics on therapeutic drugs and companies involved Adrenocortical Carcinoma (Adrenal Cortex Cancer) Pipeline candidates across ...

August 2018 90 pages

Adrenoleukodystrophy R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... is presented in user friendly and ready to use format. SCOPE OF ADRENOLEUKODYSTROPHY PIPELINE REPORT INCLUDES Panorama of Adrenoleukodystrophy pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 60 pages

African Trypanosomiasis R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF AFRICAN TRYPANOSOMIASIS PIPELINE REPORT INCLUDES Panorama of African Trypanosomiasis pipeline markets including statistics on therapeutic drugs and companies involved African Trypanosomiasis Pipeline candidates across various development ...

August 2018 40 pages

Alcohol Addiction R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF ALCOHOL ADDICTION PIPELINE REPORT INCLUDES Panorama of Alcohol Addiction pipeline markets including statistics on therapeutic drugs and companies involved Alcohol Addiction Pipeline candidates across various development ...

August 2018 110 pages

Alcoholic Hepatitis R&D Pipeline Analysis Report, H2-2018

US$ 1,980.00

... to use format. SCOPE OF ALCOHOLIC HEPATITIS PIPELINE REPORT INCLUDES Panorama of Alcoholic Hepatitis pipeline markets including statistics on therapeutic drugs and companies involved Alcoholic Hepatitis Pipeline candidates across various development ...

August 2018 60 pages

Filters

Search

Categories

60
12,968
1,223
4,429
2
1
10,890
2,818
15,138
67
8,921
1
1,229
586

Publishers

58,333

Regions

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
58,296

Price

Date

Pages

Offers